Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 2,639 | 6,627 | 3,756 | 3,794 | 5,917 |
| Gross Profit | 2,639 | 6,627 | 3,756 | 3,794 | 5,917 |
| Operating Expenses | 28,394 | 29,325 | 31,832 | 33,057 | 29,821 |
| Operating Income | -25,755 | -22,698 | -28,076 | -29,263 | -23,904 |
| Other Income | 1,320 | 1,183 | 995 | 869 | 716 |
| Pre-tax Income | -24,435 | -21,515 | -27,081 | -28,394 | -23,188 |
| Income Tax | -38 | -21 | -950 | -3,874 | -3,788 |
| Net Income Continuous | -24,397 | -21,494 | -26,131 | -24,520 | -19,400 |
| Net Income | $-24,397 | $-21,494 | $-26,131 | $-24,520 | $-19,400 |
| EPS Basic Total Ops | -1.55 | -1.40 | -1.70 | -1.65 | -1.35 |
| EPS Basic Continuous Ops | -1.55 | -1.38 | -1.71 | -1.63 | -1.36 |
| EPS Diluted Total Ops | -1.55 | -1.40 | -1.70 | -1.65 | -1.35 |
| EPS Diluted Continuous Ops | -1.55 | -1.38 | -1.71 | -1.63 | -1.36 |
| EBITDA(a) | $-24,814 | $-21,681 | $-26,974 | $-28,183 | $-22,781 |